In prostate cancer cells, TNFAIP8 can interact with ATG3 and subsequently create cellular autophagy events that promote cell survival and drug resistance (Kristensen et al., 2012; Niture et al., 2018, 2020), thereby indicating that ATG3 may play different roles in different cancers. This evidence concerns the gene ATG3 and prostate carcinoma.